Breast Cancer
Conference Coverage
How Medicare Reimbursement Trends Could Affect Breast Surgeries
A new study showed a decline in Medicare reimbursements for breast cancer surgery by more than 20% from 2003 to 2023.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Feature
Do Real-World Data Support Omitting Sentinel Lymph Node Biopsy in Early Stage Breast Cancer?
No difference in outcomes seen in patients with early breast cancer and negative presurgery ultrasound who did or did not have sentinel lymph node...
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Conference Coverage
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant Immunotherapy
Experts discuss the first randomized clinical study to assess the efficacy of immunotherapy in patients with HR+/HER2- breast cancer.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
News from the FDA/CDC
FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
The agent had already been approved for several cancer types.
Feature
Do Tumor-infiltrating Lymphocytes Predict Better Breast Cancer Outcomes?
A new study evaluates whether TILs can identify a subset of patients with triple-negative breast cancer with a very low risk of cancer recurrence...
Latest News
Older, Breastfeeding Mothers Face Differing Advice About Mammograms
Most national guidelines support routine mammograms for breastfeeding moms, but protocols in the practice setting may differ.
From the Journals
Polygenic Risk Scores Improve Breast Cancer Screening
Researchers examine how well polygenic risk scores predict a person's risk for any breast cancer as well as invasive, in situ, and bilateral at...
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...